Bcg Vaccine

The product is for intravesical instillation and is available from the Serum Institute in 40 mg and 80 mg presentations, the sources said.

In pics | All you need to know about BCG vaccine for TB that can protect humans from COVID-19

As per recent studies, the BCG vaccine -- originally for tuberculosis (TB), can provide protection against COVID-19, and several infections such as leprosy and malaria.

In Pics: All you need to know about BCG vaccine against COVID-19

A recent study has found that BCG TB vaccine can protect people against SARS-CoV-2 and lots of other pathogens.

BCG vaccine for tuberculosis protects diabetics from COVID-19: Study

The study, published in the journal Cell Reports Medicine on Monday, was conducted on 144 patients with type 1 diabetes at the start of the pandemic, much before COVID-specific vaccines were available.

Explained I New tuberculosis vaccine: why India waits with high hopes

In high-income countries, tuberculosis mainly affects the elderly, whereas in countries such as India, the disease each year takes the lives primarily of young and middle-aged adults, the most productive members of society.

Coronavirus India | BCG vaccine may help fight COVID-19 in elderly patients: ICMR study

According to the ICMR study, BCG vaccine shots induce enhanced innate and adaptive immunity among elderly patients who have tested positive for COVID-19, which may help in fighting the novel coronavirus infection.

Coronavirus pandemic | BCG vaccine could slow down COVID-19 spread, says study

Researchers have found that countries with mandatory BCG vaccination saw slower infection and death rates during the initial period of the COVID-19 outbreak.

Serum Institute conducting phase III clinical trial of BCG vaccine: DBT

About 6,000 health workers and high-risk individuals including those in close contact of COVID-19 patients have been enrolled in a clinical trial to determine if the recombinant Bacillus Calmette-Guerian (rBCG) can boost immunity to fight against the virus, the statement added.

ICMR will conduct study to find effectiveness of BCG vaccine against COVID-19

Head of Epidemiology and Communicable diseases at the Indian Council of Medical Research (ICMR) Dr Raman R Gangakhedkar said that the apex health research body will begin a study on the effectiveness of the vaccine against coronavirus infection next week.

Coronavirus pandemic | BCG vaccines cut death rate, study claims

The study analysed dataset from 178 countries of COVID-19 cases and deaths recorded from March 9-24

GreenSignal Bio Pharma IPO subscribed 3% on Day 1

The initial public offer (IPO) of vaccine manufacturing firm GreenSignal Bio Pharma was subscribed 3 per cent on the first day of the offer today.

GreenSignal Bio Pharma may raise around Rs 100 cr via IPO

Chennai-based GreenSignal Bio Pharma is likely to come out with an Initial Public Offer (IPO) in October to raise around Rs 100 crore.